Latest Regeneron News & Updates

See the latest news and media coverage for Regeneron. We track all announcements, press releases, and industry mentions in real time, all in one place.

Regeneron

Biopharmaceutical company

regeneron.com

Headquarters: Tarrytown, United States
Company type: Public company
Number of employees: 15,000+

Last updated Today

Latest news about Regeneron

In short: Regeneron achieved strong Q1 2026 results and FDA approval for the first hearing loss gene therapy, despite a Phase 3 trial failure in melanoma.

Company announcements

June 22 Regeneron

Regeneron announces FDA and EMA accept cemdisiran submissions for gMG

NDA under Priority Review with action date November 2026; EU decision expected H2 2027. Cemdisiran could be first siRNA for gMG with subcutaneous dosing four times a year.

May 28 Regeneron

Regeneron's Ebola antibody recommended by WHO for investigational use

The antibody, maftivimab, has shown broad activity against Bundibugyo virus in vitro and will be evaluated in clinical trials.

May 22 Regeneron

Regeneron's Otarmeni receives EMA filing acceptance for hearing loss

The EMA accepted the MAA for Otarmeni, a gene therapy for OTOF-related hearing loss, for review under Accelerated Assessment.

May 21 Regeneron

Regeneron: Lynozyfic achieves 100% complete response in AL amyloidosis trial

Responses were rapid with free light chain normalization by day 15; most patients showed organ improvement. Phase 2 is ongoing for registration.

Media coverage

June 22 Morningstar

Regeneron Gets FDA, EMA Review of Cemdisiran in Generalized Myasthenia Gravis

By Colin Kellaher Regeneron Pharmaceuticals said U.S. and European regulators have accepted its applications seeking approval of its cemdisiran drug candidate in the rare and...

June 15 AD HOC NEWS

Regeneron Pharma Stock (US75886F1075): Analyst support keeps the shares in view

Regeneron Pharma is in focus on Monday after an Ad-hoc-News report said the analyst consensus price target sits at about $792.65, well above the recent...

June 13 Yahoo Finance

Regeneron Broadens Pipeline With Ebola Antibody Trials And Bispecific Cancer Bets

World Health Organization prioritizes Regeneron’s maftivimab for clinical trials targeting Bundibugy...

June 12 GuruFocus

Regeneron Pharmaceuticals Inc Annual Shareholders Meeting Transc

It is 10:30 AM and time to call the Annual Meeting of Shareholders of Regeneron Pharmaceuticals Inc. to order. As you have seen in our...

Never miss news about Regeneron

Track Regeneron and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Regeneron competitors & trending companies

Browse news for competitors to Regeneron and other trending companies.